Related references
Note: Only part of the references are listed.Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older
Marie Joelle Jabagi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety
Yonas Ghebremichael-Weldeselassie et al.
STATISTICS IN MEDICINE (2022)
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
Amir Abbas Shiravi et al.
CARDIOLOGY AND THERAPY (2022)
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study
Celine Sze Ling Chui et al.
ECLINICALMEDICINE (2022)
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Rimple Kaur et al.
International Journal of General Medicine (2021)
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data
Luigi Cari et al.
JOURNAL OF AUTOIMMUNITY (2021)
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
Anton Pottegard et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Nicola P. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
Ioannis Katsoularis et al.
LANCET (2021)
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
C. R. Simpson et al.
NATURE MEDICINE (2021)
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Noam Barda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
Marion Taine et al.
FRONTIERS IN PEDIATRICS (2021)
Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
Laura Semenzato et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
Seasonal influenza vaccine and Guillain-Barre syndrome: A self-controlled case series study
Clemence Grave et al.
NEUROLOGY (2020)
The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation
Julia Stowe et al.
VACCINE (2016)
Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles/mumps/rubella immunization
Matthieu Hanf et al.
VACCINE (2013)
Case series analysis for censored, perturbed, or curtailed post-event exposures
C. Paddy Farrington et al.
BIOSTATISTICS (2009)
Large-scale simultaneous hypothesis testing: The choice of a null hypothesis
B Efron
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)